Biognost SRL
10.9 FTEBiognost reported total assets of €7.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026), with 10.9 full-time equivalents.
The score of Biognost shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +301 % Total assets +32 % Headcount (avg FTE) +7 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biognost's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 21 Jun 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
- Year ended 31 Dec 2021filed on 06 Sep 2022
Biognost's financial analysis
- Solvency67.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biognost
Biognost's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0456.661.548
- VAT number
- BE0456661548
- Peppol
- Registered · 0208:0456661548 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Dec 1995
- Registered office
- 8501 Kortrijk
- Size
- Small · 10.9 FTE
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Biognost (SRL) has been based in Kortrijk since 1995, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of €3.08m and equity of €4.92m; its revenue is not published. With 10.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 67.8%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biognost
Companies in the same business, of comparable size and area, outside its group.
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Eureka Pharma Wholesale of pharmaceutical and medical goods Kuurne · balance sheet €1.90m
- Credophar Wholesale of pharmaceutical and medical goods Ghent · balance sheet €7.84m
- ERC Pharma Wholesale of pharmaceutical and medical goods Gembloux · balance sheet €3.56m
- Celyntra Therapeutics Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet €8.20m
- Vetservices Wholesale of pharmaceutical and medical goods Kortemark · balance sheet €8.48m
- Cypress Diagnostics Wholesale of pharmaceutical and medical goods Hulshout · balance sheet €5.03m
- Contipharma Wholesale of pharmaceutical and medical goods Seraing · balance sheet €7.21m
Frequently asked questions about Biognost
What is the revenue of Biognost?
Biognost files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biognost?
In Belgium, the VAT number is the company number prefixed with BE: BE0456661548 for Biognost, if the company is VAT-registered. Its company number (CBE) is 0456.661.548.
Where is the registered office of Biognost?
According to the CBE register, the registered office of Biognost is in 8501 Kortrijk.
What is the equity of Biognost?
At the close of the 2025 financial year, the equity of Biognost amounts to 4,923,087 €, a solvency of 67.8% of total assets.
How many people work at Biognost?
10.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biognost?
The register lists 8 active mandates at Biognost. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biognost
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →